Download Free Sample Report

The global Healthcare CMO market was valued at US$ 82810 million in 2024 and is projected to reach US$ 156050 million by 2030, at a CAGR of 9.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Industry and government regulations have forced enterprises to outsource manufacturing operations to the third party to remain competitive and enhance business process efficiency. Increasing investment in the healthcare sector has also provided the necessary impetus to the market.
This report aims to provide a comprehensive presentation of the global market for Healthcare CMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare CMO. This report contains market size and forecasts of Healthcare CMO in global, including the following market information:
Global Healthcare CMO Market Revenue, 2018-2024, 2024-2030, ($ millions)
Global top five companies in 2024 (%)
The U.S. Market is Estimated at $ Million in 2024, While China is to reach $ Million.
Pharmaceutical Contract Manufacturing Services (Active Pharmaceutical Ingredients (API) Manufacturing, Final Dosage Form (FDF) Manufacturing, and Packaging) Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Healthcare CMO include Accellent, Boehringer Ingelheim, Catalent, DSM, Fareva, Greatbatch, Lonza, Patheon and Piramal, etc. in 2024, the global top five players have a share approximately % in terms of revenue.
We surveyed the Healthcare CMO companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Healthcare CMO Market, by Type, 2018-2024, 2024-2030 ($ millions)
Global Healthcare CMO Market Segment Percentages, by Type, 2024 (%)
Pharmaceutical Contract Manufacturing Services (Active Pharmaceutical Ingredients (API) Manufacturing, Final Dosage Form (FDF) Manufacturing, and Packaging)
Medical Device Contract Manufacturing Services (Outsourcing Design, Device Manufacturing (Material Process Services, Electronic Manufacturing Services, and Finished Products), and Final Goods Assembly)
Final Goods Assembly
Global Healthcare CMO Market, by Application, 2018-2024, 2024-2030 ($ millions)
Global Healthcare CMO Market Segment Percentages, by Application, 2024 (%)

• Pharmaceutical
• Biotechnology Industry

Global Healthcare CMO Market, By Region and Country, 2018-2024, 2024-2030 ($ Millions)
Global Healthcare CMO Market Segment Percentages, By Region and Country, 2024 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Healthcare CMO revenues in global market, 2018-2024 (estimated), ($ millions)
• Key companies Healthcare CMO revenues share in global market, 2024 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Accellent
• Boehringer Ingelheim
• Catalent
• DSM
• Fareva
• Greatbatch
• Lonza
• Patheon
• Piramal
• Tecomet
• Including or Excluding key companies relevant to your analysis.

Outline of Major Chapters:
Chapter 1: Introduces the definition of Healthcare CMO, market overview.
Chapter 2: Global Healthcare CMO market size in revenue.
Chapter 3: Detailed analysis of Healthcare CMO company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Healthcare CMO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.